trial
as of 2026-07-01D-amino Acid Oxidase Inhibition (DAAOI-1) add-on Treatment for Chronic Schizophrenia
NCTId NCT00960219
at a glance
Phase 2 · Completed
Enrollment 52 (actual)
Sponsored by China Medical University Hospital
Primary completion 2011-07
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 2
Status
Completed
Enrollment
52 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2009-04
Primary completion
2011-07
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
China Medical University HospitalLead Sponsor
Investigators
1
Hsien-Yuan Lane, M.D., Ph.DPrincipal Investigator
Sites
1 total
Taichung, Taiwan
Linked catalysts
1
Facts & assertions
4 sourced
Enrollment
52
Phase
PHASE2
Primary Completion Date
2011-07
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
indication
investigator